1. Home
  2. TMC vs HRMY Comparison

TMC vs HRMY Comparison

Compare TMC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMC
  • HRMY
  • Stock Information
  • Founded
  • TMC 2011
  • HRMY 2017
  • Country
  • TMC Canada
  • HRMY United States
  • Employees
  • TMC N/A
  • HRMY N/A
  • Industry
  • TMC Metal Mining
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • TMC Basic Materials
  • HRMY Health Care
  • Exchange
  • TMC Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • TMC 2.1B
  • HRMY 1.9B
  • IPO Year
  • TMC N/A
  • HRMY 2020
  • Fundamental
  • Price
  • TMC $8.74
  • HRMY $26.56
  • Analyst Decision
  • TMC Strong Buy
  • HRMY Strong Buy
  • Analyst Count
  • TMC 4
  • HRMY 10
  • Target Price
  • TMC $6.88
  • HRMY $51.30
  • AVG Volume (30 Days)
  • TMC 9.7M
  • HRMY 1.1M
  • Earning Date
  • TMC 11-13-2025
  • HRMY 10-28-2025
  • Dividend Yield
  • TMC N/A
  • HRMY N/A
  • EPS Growth
  • TMC N/A
  • HRMY 58.41
  • EPS
  • TMC N/A
  • HRMY 3.10
  • Revenue
  • TMC N/A
  • HRMY $772,527,000.00
  • Revenue This Year
  • TMC N/A
  • HRMY $19.94
  • Revenue Next Year
  • TMC N/A
  • HRMY $16.65
  • P/E Ratio
  • TMC N/A
  • HRMY $8.58
  • Revenue Growth
  • TMC N/A
  • HRMY 17.74
  • 52 Week Low
  • TMC $0.72
  • HRMY $26.13
  • 52 Week High
  • TMC $9.55
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • TMC 75.98
  • HRMY 26.97
  • Support Level
  • TMC $6.23
  • HRMY $26.56
  • Resistance Level
  • TMC $9.55
  • HRMY $27.48
  • Average True Range (ATR)
  • TMC 0.56
  • HRMY 1.00
  • MACD
  • TMC 0.32
  • HRMY -0.16
  • Stochastic Oscillator
  • TMC 85.38
  • HRMY 7.19

About TMC TMC the metals company Inc.

TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: